YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
DEFECTIVE DRUGS
Parker Waichman Alonso LLP is a leader in a defective drug litigation. We are currently evaluating cases involving the prescription drugs listed below. Please click on a specific drug or fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
FDA Looking at Possible Lantus Cancer Link
Jul 1, 2009 | Parker Waichman Alonso LLP
Lantus, a synthetic form of insulin, is the subject of an Early Communication from the Food & Drug Administration (FDA). According to the...
FDA Panel Votes To Eliminate Two Popular Painkillers
Jul 1, 2009 | Parker Waichman Alonso LLP
A government panel voted that two popular prescription painkillers be taken off of the market because of their alleged impact in dangerous, sometimes...
Group Calls For Study Of Arthritis Drugs
Jul 1, 2009 | Parker Waichman Alonso LLP
Arthritis and other autoimmune medications have made recent headlines over a variety of issues including links to serious opportunistic fungal...
FDA Meets On Acetaminophen
Jul 1, 2009 | Parker Waichman Alonso LLP
In addition to other suggestions, U.S. health advisers recommended yesterday that the maximum dose of over-the-counter (OTC) acetaminophen, be...
Chantix, Zyban Get Black Box on Mental Health Issues
Jul 1, 2009 | Parker Waichman Alonso LLP
Labeling for Chantix and Zyban will be updated to include a Black Box Warning regarding their link to mental health events, including changes...
10th Tysabri Patient Stricken with PML
Jun 30, 2009 | Parker Waichman Alonso LLP
Another Tysabri patient has developed progressive multifocal leukoencephalopathy or PML. This brings the total number of cases of the brain infection...
Company Refocuses Marketing Efforts on ReNu
Jun 30, 2009 | Parker Waichman Alonso LLP
We recently wrote that Bausch & Lomb, maker of ReNu with MoistureLoc, settled around 600 lawsuits involving the recalled contact lens solution....
Accutane Pulled from Market Amid Lawsuits, Increased Generic Competition
Jun 29, 2009 | Parker Waichman Alonso LLP
Accutane is being pulled from the market by its maker, Roche AG. According to the Associated Press, Roche said the decision to withdraw...
Lantus Studies Raise Cancer Worries
Jun 29, 2009 | Parker Waichman Alonso LLP
Lantus, the blockbuster diabetes drug made by Sanofi-Aventis, may increase the risk of cancer in some patients. The possible link, seen...
Piroxicam Linked to Serious Skin Reactions, GI Problems, Health Canada Says
Jun 26, 2009 | Parker Waichman Alonso LLP
The labeling for piroxicam has been updated in Canada to reflect increased risk of serious skin reactions and gastrointestinal problems relative to...
Gardasil Side Effect Reports Included 28 Deaths, Group Says
Jun 25, 2009 | Parker Waichman Alonso LLP
A conservative advocacy group is charging that more than 2 dozen women and girls died in 2008 after receiving Gardasil injections. ...
Risperdal Said to be Responsible for Breast Growth in Boys
Jun 25, 2009 | Parker Waichman Alonso LLP
Risperdal has been linked to breast growth, and even lactation, in boys under 18 who take the powerful antipsychotic drug. The condition is...
Defective Drugs


